Startups
OpenAI Researcher Eyes $2B AI Drug Discovery Startup with Lightspeed's Backing
Miles Wang, an OpenAI researcher, is reportedly in talks to launch an AI-driven drug discovery startup, potentially valued at $2 billion, with Lightspeed Venture Partners leading the funding round.